Introduction

One of the most common questions before a ChondroFiller injection is how soon you can walk afterwards. The reassuring answer is that, because this is a non-surgical injection rather than an operation, walking is usually possible straight away. Understanding why recovery is so straightforward — and what sensible precautions to take — helps you get the most from the procedure.

What ChondroFiller Is — and Is Not

ChondroFiller is a CE-marked Class III medical device: a type I collagen hydrogel scaffold made by Meidrix Biomedicals in Germany. When delivered as an injection, it is administered as an ultrasound-guided outpatient procedure — no incision, no theatre, no general anaesthetic. The scaffold gels in place within minutes and provides a regenerative matrix that recruits the body's own progenitor cells to support cartilage repair over time.

This injection pathway is distinct from Liquid Cartilage, which is the Lee Liquid Cartilage Protocol — a keyhole (arthroscopic) surgical procedure developed by Professor Paul Y. F. Lee. That surgical route combines the ChondroFiller scaffold with biological adjuncts and, where appropriate, the patient's own mesenchymal stem cells. It is genuine surgery requiring theatre and a structured recovery. The present article addresses only the injection pathway; people with larger or load-bearing defects may be advised to consider the surgical route instead.

Why Recovery from the Injection Is Simpler

Because the ChondroFiller injection involves no incision and no surgical wound, there is no need for the prolonged non-weight-bearing period or crutches that follow joint surgery. The joint surface has not been disturbed in the way that arthroscopy requires, so the main aim in the first days is simply to allow the scaffold to stabilise rather than to protect a surgical repair.

Easing Back Into Activity

For most people receiving the ChondroFiller injection, the typical pattern is:

• Immediate post-injection: walking is usually possible straight away; avoid sudden high-impact loading on the day itself.
• First one to two weeks: a period of relative rest and light activity helps the scaffold settle; avoid heavy impact, twisting, or prolonged loading of the joint.
• After two weeks: gradual return to normal daily activities as comfort allows, guided by how the joint feels.
• Higher-impact activities (running, sport): ease back progressively over the following weeks, following any specific guidance from your treating clinician.

Individual responses vary. Some joints — particularly small joints such as the thumb, wrist, or toes — recover especially quickly, often within one to two weeks. Larger or more loaded joints may benefit from slightly more caution in the early days. Your clinician's advice for your specific joint and defect takes precedence over any general guidance.

What the Evidence Suggests

Clinical experience with ChondroFiller across multiple joints is encouraging. In published series, patients report meaningful improvements in pain and function, though responses vary and benefits cannot be guaranteed. ChondroFiller is a regenerative scaffold that supports the body's own repair process; it is not a cure for arthritis and does not reverse established joint degeneration. Improvement typically develops gradually over the first twelve months as the scaffold is progressively replaced by the patient's own tissue.

The evidence base for ChondroFiller includes data from over 19,490 units used since 2013, with a strong safety profile. The trapeziometacarpal study by Corain and colleagues (2023) adds to this growing body of evidence across a range of joint applications.

When to Seek Advice

Contact your treating clinician if you notice increasing swelling, warmth, or pain that does not settle after a few days, or if you are unsure how to progress your activity. These are usually minor post-injection responses, but it is sensible to have them assessed.

Support at London Cartilage Clinic

Professor Paul Lee and the team at London Cartilage Clinic provide individual guidance on returning to activity after the ChondroFiller injection. Where helpful, this includes physiotherapy support and realistic advice on progression. Patients whose assessment suggests they are better suited to the Liquid Cartilage surgical protocol are guided towards that pathway instead, with a clear explanation of how the two approaches differ.

Conclusion

Recovery after the ChondroFiller injection is typically straightforward. Most people walk straight away and return to normal activities within one to two weeks, progressing to higher-impact activity over the following weeks. The simplicity of recovery reflects the non-surgical nature of the injection itself. For individual advice about your joint and your specific situation, consult a qualified musculoskeletal specialist.

References

Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.